In contrast, Mollenhauer et al. and Tokuda et al. performed ELISA to measure CSF α-synuclein levels and found significant decreases of α-synuclein in PD patients compared with non-PD controls [17,18]. This evidence concerns the gene SNCA and Parkinson disease.